OmniSpirant Therapeutics Granted US Patent for Novel RNA Delivery and Regenerative Gene Therapy Platform
OmniSpirant Therapeutics announces a US patent grant for its "Extracellular Vesicles for Inhalation" technology with enhanced delivery properties. GALWAY, GALWAY, IRELAND, August 16, 2024 /EINPresswire.com/ -- OmniSpirant Therapeutics Receives Notice of Grant for US [...]
OmniSpirant Limited Appoints Andy Fisher to its Board of Directors
Galway, Ireland 4th May 2023 OmniSpirant is excited to announce the appointment of Andy Fisher to its board of directors. For nearly 20 years, Andy held leadership positions at United Therapeutics Corporation, a global biotechnology [...]
Emily’s Entourage Grants $220k to Queen’s University Belfast to advance OmniSpirant’s Gene Therapy for Cystic Fibrosis
PRESS RELEASE We are excited to progress the development of OS001 for CF in collaboration with Prof Lorraine Martin and Dr Lisa Douglas in Queen's University Belfast. Funding support from Emily's Entourage in the USA [...]
OmniSpirant Limited Announces the Launch of INSPIRE; an EU Project funded under the Horizon Europe research and innovation programme to develop a ground-breaking inhaled gene therapy for the treatment of lung cancer.OmniSpirant Limited Announces the Launch of INSPIRE; an EU Project funded under the Horizon Europe research and innovation programme to develop a ground-breaking inhaled gene therapy for the treatment of lung cancer.
OmniSpirant Limited Announces the Launch of INSPIRE; an EU Project funded under the Horizon Europe research and innovation programme to develop a ground-breaking inhaled gene therapy for the treatment of lung cancer.
PRESS RELEASE OmniSpirant Limited are delighted and honoured to announce the launch of INSPIRE, a €12.8 million lung cancer project funded by Horizon Europe. In one of the largest ever grants for preclinical research in [...]
OmniSpirant Named in the World’s Top 5 Startups Developing Drugs for Respiratory Disease
StartUs insights analysis of the global respiratory drug development landscape highlights OmniSpirant's inhaled regenerative gene therapy platform: Omnispirant explores Inhaled Gene Therapy In the last decade, advances in gene sequencing and gene editing have made [...]
Irish Consortium to Develop Novel Treatment for ARDS and COPD
Pictured from left to right: Dr Janusz Krawczyk, Dr Róisín Dwyer, Prof John Laffey, Dr Ronan MacLoughlin, Gerry McCauley, Dr Daniel O’Toole and Dr Katie Gilligan NUI Galway, OmniSpirant Limited and Aerogen Limited have [...]
